Comparisons of tumor-infiltrating lymphocytes and 21-gene recurrence score in ER-positive/ HER2-negative breast cancer

被引：0
|
作者：
Ahn, S. G. [1 ]
Cha, Y. J. [2 ]
Yoon, C. [1 ]
Bae, S. J. [1 ]
Kim, J. [3 ]
Jeong, J. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Surg, Seoul, South Korea
[2] Gangnam Severance Hosp, Pathol, Seoul, South Korea
[3] Kangnam Mizmedi Hosp, Surg, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer
    Ahn, Sung Gwe
    Cha, Yoon Jin
    Bae, Soon June
    Yoon, Chanik
    Lee, Hak Woo
    Jeong, Joon
    [J]. BMC CANCER, 2018, 18
  • [2] Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer
    Sung Gwe Ahn
    Yoon Jin Cha
    Soon June Bae
    Chanik Yoon
    Hak Woo Lee
    Joon Jeong
    [J]. BMC Cancer, 18
  • [3] Tumor-infiltrating lymphocytes (TILs) and 21-gene recurrence score in 1,883 patients with ER+/HER2-breast cancer
    Ahn, Sung Gwe
    Jang, Ji Soo
    Kook, Yoonwon
    Baek, Seung Ho
    Lee, Sae Byul
    Bae, Soong June
    Jeong, Joon
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [4] Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients
    Pousette, Jenny
    Johansson, Annelie
    Jonsson, Carolin
    Fornander, Tommy
    Lindstrom, Linda S.
    Olsson, Hans
    Perez-Tenorio, Gizeh
    [J]. CANCERS, 2022, 14 (19)
  • [5] High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer
    Oshi, Masanori
    Angarita, Fernando A.
    Tokumaru, Yoshihisa
    Yan, Li
    Matsuyama, Ryusei
    Endo, Itaru
    Takabe, Kazuaki
    [J]. CANCERS, 2020, 12 (12) : 1 - 15
  • [6] Abundance of tumor-infiltrating lymphocytes is associated with pathologic complete response to neoadjuvant chemotherapy but not with survival in ER-positive/HER2-negative breast cancer
    Wu, Rongrong
    Nagahashi, Masayuki
    Oshi, Masanori
    Miyoshi, Yasuo
    Ishikawa, Takashi
    Takabe, Kazuaki
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [7] Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer
    Poorvu, Philip D.
    Gelber, Shari, I
    Rosenberg, Shoshana M.
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Collins, Laura C.
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia F.
    Come, Steven E.
    Warner, Ellen
    Jakubowski, Debbie M.
    Russell, Christy
    Winer, Eric P.
    Partridge, Ann H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 725 - +
  • [8] Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)
    Bernhard C. Pestalozzi
    Christoph Tausch
    Konstantin J. Dedes
    Christoph Rochlitz
    Stefan Zimmermann
    Roger von Moos
    Ralph Winterhalder
    Thomas Ruhstaller
    Andreas Mueller
    Katharina Buser
    Markus Borner
    Urban Novak
    Catrina Uhlmann Nussbaum
    Bettina Seifert
    Martin Bigler
    Vincent Bize
    Simona Berardi Vilei
    Christoph Rageth
    Stefan Aebi
    [J]. BMC Cancer, 17
  • [9] Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay
    Ahn, Sung Gwe
    Bae, Soong June
    Yoon, Changik
    Cha, Yoon Jin
    Lee, Hak Woo
    Lee, Seung Ah
    Jeong, Joon
    [J]. PLOS ONE, 2017, 12 (11):
  • [10] Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)
    Pestalozzi, Bernhard C.
    Tausch, Christoph
    Dedes, Konstantin J.
    Rochlitz, Christoph
    Zimmermann, Stefan
    von Moos, Roger
    Winterhalder, Ralph
    Ruhstaller, Thomas
    Mueller, Andreas
    Buser, Katharina
    Borner, Markus
    Novak, Urban
    Nussbaum, Catrina Uhlmann
    Seifert, Bettina
    Bigler, Martin
    Bize, Vincent
    Vilei, Simona Berardi
    Rageth, Christoph
    Aebi, Stefan
    [J]. BMC CANCER, 2017, 17
12345